Most high-income countries have secured an abundant supply of COVID-19 vaccines. However, to these researchers’ knowledge, there is no assessment of the pragmatic effectiveness of the COVID-19 vaccines used in low- and moderate-income countries.
Published by the JAMA Network on October 29, 2021, researchers conducted an Original Investigation that found a pragmatic implementation of a group of COVID-19 vaccines was associated with a dramatic reduction in documented COVID-19 infection.
Read More
